Trademark: 87576884
Status Date
Tuesday, August 14, 2018
Registration Number
5538768
Registration Date
Tuesday, August 14, 2018
Filing Date
Monday, August 21, 2017
Published for Opposition
Tuesday, May 29, 2018
5 Pharmaceutical preparations for use in the treatment of cancer and immune related diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
44 Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries
42 Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others; providing an interactive website featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports
As to "IMIDS"
"FOUNDATION"
Aug 14, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 9, 2022
Teas Change Of Correspondence Received
Dec 9, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 9, 2022
Teas Change Of Owner Address Received
Aug 14, 2018
Registered-Principal Register
May 29, 2018
Official Gazette Publication Confirmation E-Mailed
May 29, 2018
Published For Opposition
May 9, 2018
Notification Of Notice Of Publication E-Mailed
Apr 26, 2018
Electronic Record Review Complete
Apr 20, 2018
On Hold - Electronic Record Review Required
Apr 12, 2018
Approved For Pub - Principal Register
Apr 12, 2018
Examiner's Amendment Entered
Apr 12, 2018
Notification Of Examiners Amendment E-Mailed
Apr 12, 2018
Examiners Amendment E-Mailed
Apr 12, 2018
Examiners Amendment -Written
Apr 11, 2018
Teas/Email Correspondence Entered
Apr 11, 2018
Correspondence Received In Law Office
Apr 11, 2018
Teas Response To Office Action Received
Apr 3, 2018
Notification Of Non-Final Action E-Mailed
Apr 3, 2018
Non-Final Action E-Mailed
Apr 3, 2018
Non-Final Action Written
Feb 15, 2018
Teas/Email Correspondence Entered
Feb 15, 2018
Correspondence Received In Law Office
Feb 14, 2018
Assigned To Lie
Feb 6, 2018
Teas Response To Office Action Received
Nov 28, 2017
Notification Of Non-Final Action E-Mailed
Nov 28, 2017
Non-Final Action E-Mailed
Nov 28, 2017
Non-Final Action Written
Nov 21, 2017
Assigned To Examiner
Aug 25, 2017
New Application Office Supplied Data Entered
Aug 24, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
